Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EBT: 2019-2025

Historic EBT for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to $17.2 million.

  • Burning Rock Biotech's EBT fell 91.01% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.9 million, marking a year-over-year decrease of 107.19%. This contributed to the annual value of -$46.7 million for FY2024, which is 49.11% up from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's EBT is $17.2 million, which was up 182.36% from -$20.9 million recorded in Q2 2025.
  • Burning Rock Biotech's EBT's 5-year high stood at $614.4 million during Q4 2022, with a 5-year trough of -$231.5 million in Q3 2022.
  • Its 3-year average for EBT is $230,636, with a median of -$20.9 million in 2025.
  • Over the last 5 years, Burning Rock Biotech's EBT had its largest YoY gain of 1,615.87% in 2022, and its largest YoY loss of 773.26% in 2022.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's EBT stood at -$40.5 million in 2021, then surged by 1,615.87% to $614.4 million in 2022, then crashed by 35.15% to $398.4 million in 2023, then crashed by 102.25% to -$9.0 million in 2024, then crashed by 91.01% to $17.2 million in 2025.
  • Its EBT was $17.2 million in Q3 2025, compared to -$20.9 million in Q2 2025 and -$13.3 million in Q1 2025.